Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Kathy Oxtoby asks what optometrists need to know about antimicrobial resistance.

Many people suffering from hypertension don’t even know they have a problem. But in the right setting, writes Léa Surugue, Optometrists can be part of the solution.

Consultant Ophthalmologist Damian Lake looks at the history of corneal collagen cross-linking in treating keratoconus, the current indications for its use, and the most up-to-date refinements to the procedure.